Member Info for Oily1990

I’ve added - MD when you seem to post on here you seem to have a sixth sense and the price heads up. Tim to drop a podcast over the weekend or an rns on Monday - let’s see

I’m sure many will wonder in hindsight if they should have bought as I personally believe we are set for a significant move - added 60k this morning as I have funds

Bit late here today but I’ve had to break my buy into 2 - couldn’t get a quote on 100k, but 50k was fine.

I’d be looking at circa £1.20 and as high as £1.40 - so great opportunity here

The point I think some are missing is that we are at historic lows and official news of reinstatement of pipeline exports opening up after a near 3 year shut in will see the price of the shares jump significantly higher. Hence buying now is the perfect time if there was one.

Yes they have raised cash and the devil is in the details along with the price they have raised at - 3.75p. This isn’t a negative but with this now out of the way we will refocus on what impact P140 and the pipeline of of other drugs will bring to the business

Well we all are invested with the view this is worth significantly more than the current market cap / let’s agree on that and wait for the rest

Well I was hearing Moderna and the way the sp shows signs of considerable strength even if this turns out to be pie in the sky there is certainly accumulation taking place

Seems to be the sensible thing to do - I have. So much for my info on Moderna/ Roche - nothing yet

Well like I had posted and previously and ignored …..Moderna and/or Roche

I’m not speculating on price but like I posted last week the name Moderna had come up and more recently Roche - I have skin in the game and am happy to ride this higher. Blockbuster interview by the CEO - you can see he was hamstrung in what he wanted to say. Wait for the news on P140, patents and strategic partnerships. We are well on our way imho

Well these are by no means facts, but like I posted last week Moderna seemed onboard, but Roche apparently also entered the fray. Certainly don’t buy on the basis of my post, but since I have added over the last couple days I thought why not share on here as it’s all drivel lol. Now a case of waiting to see if these whispers have any merit.

Those exiting here I’d say look at Imm - it’s at the same bio tech conference but has a genuine last stage drug that can address lupus. You saw what a deal did here with Johnson and Johnson, well rumour is that a big French player could be interested - official announcement pending

Link the dots from the last 3 rns’ - change of auditor - due diligence? Well we will see soon enough

If this is true then we could be in for a bumper rerate. It’s what I’ve heard

Well there was the smallest of shakes and if you were lucky you got some at 3.45p having seen the bid hit 3.75 today. We have seen some significant buys and equally some large sells, but one thing became clear in the afternoon the MMs were picking up what they could. There is clearly a large buyer in the background. I expect some significant buying again tomorrow and the buy volume to be even higher than today. The early sellers are out and we can see this re-rate to a sensible level before the US bio-Tech conference, which commences on 11/1.

Now re-reading what was released yesterday by the company, along with the update this morning I believe holders are rightfully optimistic about what is happening right now. Over a quite a long period we have seen posters claiming the problem with Tim is the “Jam Tomorrow” updates……..well one thing is clear to me the jam is here and anyone that wants a slice can get onboard, for what will look like a gift in the short term.

What we know about the conference:

The JP Morgan conference and Biotech Showcase are annual premier partnering events, designed to provide biotechnology companies with the opportunity to present to and connect with global Biopharma companies and investors.

The advances made by ImmuPharma with the P140 program, particularly in the latter part of 2024, have led to significant interest from leading Biopharmaceutical companies and we are progressing discussions as we move to establish global licensing agreements.

Let’s say it seems clear there may well be multiple interested parters in the results from P140. The details of the P140 Studies will more than likely be shared first hand over the course of this conference and shared with holders next week.

My view is to buy what you can at these levels, because Immupharma’s current market valuation is still sub £16m

It’s a case of adding at these prices because we will be breaking back over 20p tomorrow. Asset purchase to be announced imminently. Cash and earning make this a no brainer for me sub 27p right now

Looks as though we are getting that hint of a bullish move higher - I’d expect the offer to get back towards 2p as the news on trials come through.

All indicators are pointing up and this really does looked primed to make a solid move. This is the novice Chartist speaking I’ll leave the Gaps to Maverick

Certainly looking better a week on a with the volume today you know it’s the funds leading the charge up. End of this week and we should be closer to 30 than we are 20 right now.